2019. Orally administered fisetin as an immuno-modulatory and therapeutic agent in a mouse model of chronic allergic airway disease. Biomedical Research and Therapy. 6, 7 (Jul. 2019), 3262–3273. DOI:https://doi.org/10.15419/bmrat.v6i7.553.